RIPK1 and Alzheimer disease: We also detected necroptosis stimulation, NF-κB activation, and induced cytokine storms in a the TauP301S AD mouse model and observed that RIPK1 inhibition effectively ameliorated the behavioral deficits and excessive neuroinflammation activation in AD mice.